关注
Gülistan Karadeniz
Gülistan Karadeniz
Sağlık Bilimleri Üniversitesi, İzmir Tıp Fakültesi, Göğüs Hastalıkları
在 sbu.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
The impact of charlson comorbidity index on mortality from SARS‐CoV‐2 virus infection and A novel COVID‐19 mortality index: CoLACD
Y Varol, B Hakoglu, A Kadri Cirak, G Polat, B Komurcuoglu, B Akkol, ...
International journal of clinical practice 75 (4), e13858, 2021
522021
Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease
G Karadeniz, S Aktoğu, OF Erer, SB Kır, S Doruk, M Demir, K Sonat
Biomarkers in Medicine 10 (7), 701-710, 2016
392016
C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations
G Karadeniz, G Polat, G Senol, M Buyuksirin
Inflammation 36 (4), 948-953, 2013
362013
İç hastalıkları hemşireliğinde teoriden uygulamaya temel yaklaşımlar
G Karadeniz
Ankara: Baran Ofset, 2008
222008
Effects of a home-based pulmonary rehabilitation program with and without telecoaching on health-related outcomes in COVID-19 survivors: a randomized controlled clinical study
H Şahın, İ Naz, G Karadeniz, O Süneçlı, G Polat, O Ediboğlu
Jornal Brasileiro de Pneumologia 49 (01), e20220107, 2023
202023
The impact of anti-smoking laws on high school students in Ankara, Turkey
M Demir, G Karadeniz, F Demir, C Karadeniz, H Kaya, D Yenibertiz, ...
Jornal Brasileiro de Pneumologia 41 (6), 523-529, 2015
182015
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR
M Gayaf, G Karadeniz, F Güldaval, G Polat, M Türk
Expert Review of Respiratory Medicine 15 (6), 845-851, 2021
172021
Contribution of cell block obtained by thoracentesis in the diagnosis of malignant pleural effusion
F Güldaval, C Anar, G Polat, M Gayaf, MY Yavuz, A Korkmaz, İO Alıcı, ...
Journal of cytology 36 (4), 205-208, 2019
172019
Can the level of crp in acute pulmonary embolism determine early mortality?
M Büyükşirin, C Anar, G Polat, G Karadeniz
Turkish Thoracic Journal 22 (1), 4, 2021
142021
Insidious Hughes Stovin syndrome: journey from pulmonary embolism to pulmonary arterial aneurysm
M Keskin, G Polat, A Ayrancı, G Karadeniz, FD Üçsular, M Büyükşirin, ...
Turkish Thoracic Journal 21 (5), 350, 2020
132020
Correlation between chest CT severity scores and clinical and biochemical parameters of COVID‐19 pneumonia
B Komurcuoglu, S Susam, Ö Batum, MA Turk, B Salik, G Karadeniz, ...
The Clinical Respiratory Journal 16 (7), 497-503, 2022
122022
Immunization in the chronic obstructive pulmonary disease: can we have really done it
OF Erer, G Karadeniz, D Gazibaba, G Ürpek, E Yalnız, SÖ Aktoğu
İzmir Göğüs Hastanesi Dergisi 27 (1), 31-40, 2013
112013
Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hypersensitivity pneumonia
F Üçsular, G Polat, G Karadeniz, A Ayranci, M Keskin, M Buyukşirin, ...
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 37 (4), 2020
102020
Predictive value of platelet-to-lymphocyte ratio in patients with sarcoidosis
E Yalnız, G Karadeniz, FD Üçsular, G Erbay Polat, GV Şahin
Biomarkers in Medicine 13 (3), 197-204, 2019
102019
KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞINDA AŞILANMA; GERÇEKTEN YAPTIRTIYOR MUYUZ?
OF ERER, G KARADENİZ, D GAZİBABA, G ÜRPEK, E YALNIZ, ...
İzmir Göğüs Hastanesi Dergisi 27 (1), 31-40, 2013
102013
A rare complication of acupuncture: pneumothorax
M Demir, M Oruç, A Dallı, H Kaya, G Karadeniz
Tuberkuloz ve toraks 62 (4), 316-318, 2014
92014
Evaluation of the relationships between procalcitonin and neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with pneumonia
E Çil, G Karadeniz, S Yenigün, G Çoraplı
Eur. Rev. Med. Pharmacol 26, 3200-3205, 2022
62022
Are idiopathic pulmonary fibrosis patients more anxious and depressive than patient’s with other interstitial lung disease?
E Yalnız, G Polat, F Demirci, S Deniz, G Karadeniz, E Aydınlı, G Vayisoglu, ...
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 36 (4), 294, 2019
62019
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
F Ucsular, G Karadeniz, C Karadeniz, E Yalnız, M Demir
Sarcoidosis Vasc Diffuse Lung Dis 33 (2), 151-6, 2016
62016
What are the differences between smoker and non-smoker COPD cases? Is it a different phenotype?
F Güldaval, G Polat, S Doruk, G Karadeniz, A Ayranci, M Türk, M Gayaf, ...
Turkish Thoracic Journal 22 (4), 284, 2021
52021
系统目前无法执行此操作,请稍后再试。
文章 1–20